AMH and inflammatory bowel disease: The AMH in IBD patients not using thalidomide (2.68 ± 2.06 μg/L) was lower than that of healthy subjects (5.61 ± 5.06 μg/L), P = 4.80 × 10–6, but higher than that of IBD patient using thalidomide (0.85 ± 0.81 μg/L), P = 2.42 × 10–9.